It has been possible to achieve chemical suppression of immunological responsiveness by several classes of compounds. The most successful drugs used in the past have been the alkylating agents (1), the antipurines (2), the folic acid antagonists (3, 4) , and actinomycin D (5, 6) . Further study of the problem of chemical immune suppression is warranted both because of the fundamental information about immune responsiveness that may be gained from such investigations and because of the continuing clinical need for effective agents.
In the present report we described our results in the rat with vincristine and vinblastine,' examples of a new class of immunosuppressive drugs (7) . Derived from the common periwinkle plant Vinca rosea and chemically characterized as dimeric alkaloids containing both the indole and dihydroindole moieties (8) , the compounds were discovered independently by Noble, Beer, and Cutts (9)2 and a group of investigators including Johnson, Armstrong, Gorman, and Burnett (8, 10) .3 Because these drugs have been shown to be effective against a variety of experimental ( 11) and human lymphoid neoplasms (8, 12, 13) , it appeared logical to try them as inhibitors of immune responses. We have found that not only do they inhibit antibody formation, delayed hypersensitivity, and homograft rejection, but they promptly suppress established delayed hypersensitivity. Furthermore, since one of the drugs * Submitted for publication November 13, 1963 ; accepted August 28, 1964. This investigation was supported by grant CA-07179 from the National Cancer Institute. This is publication no. 1185 of the Cancer Commission of Harvard University. 1 Both obtained from Lilly Laboratories, Indianapolis, Ind.
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(vinblastine) produces marked leukopenia and the other (vincristine) does not (8) , an opportunity was afforded to assess the role of the circulating lymphocyte in the several forms of immune responsiveness. Methods
Imninzinzation. Male inbred Fischer rats weighing 120 to 135 g were used for the experiments described in Tables I, II, and III, experiment 1 of Table IV , and the first experiment of Table VI. The remaining experiments were done with non-inbred Sprague-Dawley rats of the same age and sex.4 Animals were immunized to bovine serum albumin (BSA) and tuberculin [old tuberculin (OT)] by the injection into a rear foot pad (14) of 0.1 ml of Freund's adjuvant, containing 0.5 mg bovine serum albumin and 0.3 mg killed whole tubercle bacilli. Delayed hypersensitivity and Arthus reactivity were evaluated by the intradermal injection of 0.1 ml of saline containing 30 ,ug of bovine serum albumin and 0.1 ml of a 1 to 10 saline dilution of OT into opposite shaved and depilated (Nair) flanks. The figures for delayed hypersensitivity recorded in the tables are the average diameter of induration of the skin test 24 hours after testing, and the Arthus reactions represent the induration 4 hours after testing. (Although we record average induration of 2 mm, probably 3 mm is the minimal significant reaction). Antibody formation to bovine serum albumin was measured in sheep cell-absorbed serum obtained from tail blood with tanned, formalinized sheep cells and the Microtiter apparatus (15) . Fresh sheep cells 5 were formalinized, tanned, and coated with 0.5 mg bovine serum albumin per ml cells (16 Microscopic study was not done. No difficulty was experienced in estimating the day of rej ection except in the case of several drug-treated animals who rej ected after day 30 and in whom a subtle and protracted graft rejection took place over a 5-to 7-day period. A single donor animal was used to supply the grafts for each of the grafting experiments. Drug administration. In Fischer and Sprague-Dawley rats vincristine and vinblastine administration at the level of 0.100 mg per kg for 21 days is usually well tolerated. For maximal immune suppression, particularly necessary for depression of homograft rejection, higher drug dosage is required, and we have found it advisable to weigh the animal before each injection and omit the drug in the face of excessive weight loss. We have injected only by intraperitoneal route and have found that peritoneal irritation is reduced when the drug is injected in a large volume of saline (usually about 1.0 ml). We have not experimented widely with the drug regimen, and it is quite likely that our schedule is not optimal.
Miscellaneous. Leukocyte counts and differential blood smears were done on tail blood using standard clinical techniques. Lymphocyte size was determined on smears stained with Wright's stain by micrometer measurement of individual cell diameters (at least 100 cells counted). Cells 11 A or larger were considered large lymphocytes, those 8.5 to 11 A medium lymphocytes, and those below 8.5 a small lymphocytes. Banal inflammation was determined by the intradermal injection into one shaved flank of 0.05 ml of turpentine (1: 20 in olive oil), and the induration of the resulting inflammatory response was read at 24 hours.
Results
Effect on sensitization with bovine serum albumin (BSA) and tuberculin. At high drug levels, vincristine (0.100 and 0.200 mg per kg) and vinblastine (0.200 mg per kg), suppression of antibody formation and delayed hypersensitivity to bovine serum albumin were complete during the period of drug administration. In the same animals that showed complete depression of the bovine serum albumin response, however, depression of tuberculin sensitivity was only partial. (Some of the drugtreated animals showed minimal tuberculin reactions that possessed a peculiar blanched quality). Lower dosage of drug, vincristine (0.025 and 0.050 mg per kg) and vinblastine (0.100 mg per kg), caused partial suppression of immune responses, and in general, the suppression of antibody and of delayed hypersensitivity to bovine serum albumin closely paralleled each other in the particular animal. Seven days after stopping the drugs immune suppression remained, but after 3 weeks antibody formation and minimal delayed reactions to bovine serum albumin appeared in the vincristine animals and in one vinblastine animal.
Without histological study, it is possible that the 24-hour reactions of Table I may be caused in part by immediate-type hypersensitivity. Such an occurrence could account for the greater depression of bovine serum albumin hypersensitivity observed. However, careful examination of the 24-hour rat skin reaction both to bovine serum albumin and tuberculin has revealed histology that other investigators (14) have concluded is typical of delayed reactions.
As a preliminary experiment (Table I) , four animals were selected after the development of good delayed reactions and given vinblastine (no. Suppression of established delayed hypersensitivity. In the experiment described in Table II , animals received varying doses of vincristine and vinblastine over a 3-to 7-day period. 21 Table III . Again, the correlation is not close between the depression of lymphocytes of any particular size with the loss of delayed hypersensitivity.
Arthus reaction and banal inflammntation. Exp. * The period of vincristine administration was 11 days in duration at a level of 0.2 mg per kg per day and has been enclosed within a rectangle. Vincristine was begun on the day of immunization with BSA (day 0) in group II, on day 2 in group III, on day 4 in group IV, and on day 7 in group V.
t Indicates day on which shaving and depilation were required for skin testing.
was started on day 7 after immunization, after antibody had appeared (group V). An abrupt cessation of antibody formation must occur when the drug is given, since after 7 days of treatment anti-bovine serum albumin antibody had disappeared from the blood of group V animals. Antibody formation begins in the various drug-treated animals about 7 to 10 days after the cessation of vincristine injections. Both immediate (Arthus) and delayed skin reactions were determined in the animals presented in Table V , but they are not included in the table. Arthus reactivity appeared for the first time about 2 weeks after the drug was stopped at a time when antibody levels were high, but delayed reactions appeared somewhat later and were never of more than moderate intensity (6 mm in diameter or less). In the course of shaving and depilating the animals for skin testing, a particularly interesting observation of the effect of vincristine on hair growth was made. The days on which it was necessary to shave the animals for skin testing are indicated in Table V . Although control animals required shaving every 7 to 10 days, animals on vincristine did not require shaving while on the drug. As indicated in the table, it was only some 2 to 3 weeks after the cessation of drug that shaving was again necessary. Thus the resumption of hair growth parallels the resumption of immunological reactivity.
Skin grafting. (29) .
Vincristine also inhibits the inflammatory response to injected turpentine, another property it shares with 6-mercaptopurine (30) . This antiinflammatory action of vincristine may contribute to the depression of delayed hypersensitivity, and the combination of anti-inflammatory effect, depression of polymorphonuclear leukocytes (8) , and curtailment of antibody formation could explain the inhibition of Arthus reactivity observed.
IMMUNE SUPPRESSION BY VINCRISTINE AND VINBLASTINE
The anti-inflammatory action of the drug, however, cannot be responsible for the suppression of antibody formation, and we feel that of itself it is very unlikely that this anti-inflammatory effect accounts for the inhibition of delayed hypersensitivity. Certainly, the depression of delayed hypersensitivity is more intense and prolonged than the depression of turpentine inflammation (see Table III ).
The parallel depression and recovery of immunological reactivity and hair growth give credence to the view that the immune suppression of vincristine is a manifestation of the inhibition of cell division of a number of drug-sensitive cell types. Cellular proliferation is intimately associated with immunological reactivity (31) , and vincristine and vinblastine cause metaphase arrest in tissue culture (8) . Thus the striking immunological impairment seen with vincristine could be reasonably attributed to the inhibition of proliferation of one or more types of immunologically competent lymphoid cells and a similar inhibition of the generation of inflammatory cells. The remarkable rapidity with which delayed hypersensitivity is suppressed and early antibody production ceases (Tables II and V) suggests, if such a mechanism is correct, that both are mediated by cells of very limited life span (a few days) in a state of rapid turnover. A life span of a few days has been attributed to antibody-forming cells from other data (31) .
Other immunosuppressive agents studied to date have also been potent inhibitors of cell division and, like the periwinkle alkaloids, have been drawn from the field of cancer chemotherapy. On a biochemical level, this inhibition of mitosis has been mediated through a nucleic acid mechanism. Thus in the case of the alkylating agents (32) , the antipurines (33) , and the folic acid antagonists (34), inhibition of DNA synthesis appears to be responsible for the inhibition of mitosis, although an RNA mechanism has not been ruled out. The mechanism of action of actinomycin D is probably through DNA-dependent RNA synthesis (35) . Although it is not unlikely that the periwinkle drugs act in the same manner as the other immunosuppressive agents, i.e., on nucleic acid synthesis, particularly synthesis of DNA, at present the evidence for this mechanism is preliminary (8) .
It is also plausible that immunosuppressive agents exert their effect by inhibiting synthesis of the RNA template (messenger-RNA), as originally suggested by Schwartz, Eisner, and Dameshek (2) . Finally, there is nothing to exclude the possibility of these drugs acting on both mitosis and template-RNA synthesis, a formulation that would help to explain the complexities of the suppression. Until more is known of the detailed biochemical events of immunological responsiveness, any proposed mechanism of immunological suppression must be tentative.
In the present experiments, with continuing stimulation of the original antigen-containing Freund's adjuvant, our animals displayed good antibody formation and modest delayed reactions to bovine serum albumin 2 to 3 weeks after the drug was stopped. Our failure to observe the tolerance seen in the 6-mercaptopurine system (36) is as likely attributable to a difference in the method of immunization (single intravenous injection in the case of 6-mercaptopurine), quantity of antigen, or of species, as to a fundamental difference in the mode of action of the several agents (37) . Both 6-mercaptopurine (2, 38, 39) and neonatal antigen exposure (40) , like vincristine and vinblastine, inhibit antibody formation and delayed hypersensitivity to protein antigens and homograft rejection. As in neonatal tolerance (40, 41) , we find suppression of reactivity to protein antigens more easily achieved than the suppression of hypersensitivity to tuberculin (Table I) .
\NVhether the periwinkle drugs will prove of value in suppressing the homograft reaction in man is entirely speculative, since there has been marked species variation in the effectiveness of the known immunosuppressive agents (37, 40) . The action of vincristine and vinblastine against human lymphoid neoplasms is encouraging, but in the rat at least, it has been more difficult to suppress the skin homograft reaction than other forms of imnmunological reactivity.
Summary
The dimeric alkaloids vincristine and vinblastine, derived from the periwinkle plant Vinca rosea, have been found to be potent immunosuppressive agents in the rat. When administered at 2401 the time of immunization with bovine serum albumin in complete Freund's adjuvant, antibody formation and delayed hypersensitivity to bovine serum albumin are completely suppressed, and hypersensitivity to tuberculin is markedly reduced. At high vincristine dosage, established delayed hypersensitivity to these antigens was promptly and regularly abolished, early antibody formation ceased, and homograft rejection was substantially delayed. Lesser degrees of inhibition of the inflammatory response to turpentine and Arthus reactivity were seen, and hair growth stopped while the drug was administered. A profound and consistent depression of small, medium, or large lymphocytes in the peripheral blood was not observed during immune suppression with vincristine. We felt that the mechanism of the immunosuppressive action of vincristine most likely involved inhibition of the proliferation of one or more immunologically competent lymphoid cells, probably through a DNA mechanism.
